← Back to Search

The Role of Platelet Rich Plasma for Erectile Dysfunction

Phase 3
Waitlist Available
Led By Chris Deibert, MD, MPH
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* history of mild to moderate erectile dysfunction measured by IIEF
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1, 3 and 6 months
Awards & highlights
Pivotal Trial

Summary

This trial is testing whether injecting a concentrated solution of a man's own blood into his penis can help improve erectile function. The study focuses on men aged 50-80 who have erectile dysfunction. This solution is thought to work by using growth factors in the blood to heal and improve tissue health.

Eligible Conditions
  • Erectile Dysfunction

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1, 3 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1, 3 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Erectile Function Change
Other study objectives
Side Effects

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Platelet rich plasmaExperimental Treatment1 Intervention
All arms will have phlebotomy (blood drawn). This group will receive PRP injection only.
Group II: PlaceboPlacebo Group1 Intervention
All arms will have phlebotomy (blood drawn). This group will receive saline injection only.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Platelet rich plasma
2010
Completed Phase 4
~1300

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
555 Previous Clinical Trials
1,145,372 Total Patients Enrolled
Chris Deibert, MD, MPHPrincipal InvestigatorUniversity of Nebraska
Chris Deibert, MD, MPJHPrincipal InvestigatorUniversity of Nebraska
~3 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top